These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35798129)

  • 1. A brief history of long circulating nanoparticles.
    Haroon HB; Hunter AC; Farhangrazi ZS; Moghimi SM
    Adv Drug Deliv Rev; 2022 Sep; 188():114396. PubMed ID: 35798129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of Hepatic Macrophages by Therapeutic Nanoparticles.
    Colino CI; Lanao JM; Gutierrez-Millan C
    Front Immunol; 2020; 11():218. PubMed ID: 32194546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of removing Kupffer cells on nanoparticle tumor delivery.
    Tavares AJ; Poon W; Zhang YN; Dai Q; Besla R; Ding D; Ouyang B; Li A; Chen J; Zheng G; Robbins C; Chan WCW
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E10871-E10880. PubMed ID: 29208719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kupffer cell-targeting strategy for the protection of hepatic ischemia/reperfusion injury.
    Dai Q; Jiang W; Liu H; Qing X; Wang G; Huang F; Yang Z; Wang C; Gu E; Zhao H; Zhang J; Liu X
    Nanotechnology; 2021 Apr; 32(26):. PubMed ID: 33472187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-circulating and target-specific nanoparticles: theory to practice.
    Moghimi SM; Hunter AC; Murray JC
    Pharmacol Rev; 2001 Jun; 53(2):283-318. PubMed ID: 11356986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular distribution of injected PLGA-nanoparticles in the liver.
    Park JK; Utsumi T; Seo YE; Deng Y; Satoh A; Saltzman WM; Iwakiri Y
    Nanomedicine; 2016 Jul; 12(5):1365-74. PubMed ID: 26961463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles disguised as red blood cells to evade the immune system.
    Fang RH; Hu CM; Zhang L
    Expert Opin Biol Ther; 2012 Apr; 12(4):385-9. PubMed ID: 22332936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging.
    Heneweer C; Gendy SE; Peñate-Medina O
    Ther Deliv; 2012 May; 3(5):645-56. PubMed ID: 22834408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capture of stealth nanoparticles by the body's defences.
    Moghimi SM; Hunter AC
    Crit Rev Ther Drug Carrier Syst; 2001; 18(6):527-50. PubMed ID: 11789674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].
    Ozeki T; Tagami T
    Yakugaku Zasshi; 2021; 141(3):323-326. PubMed ID: 33642498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organosilica Cages Target Hepatic Sinusoidal Endothelial Cells Avoiding Macrophage Filtering.
    Talamini L; Picchetti P; Ferreira LM; Sitia G; Russo L; Violatto MB; Travaglini L; Fernandez Alarcon J; Righelli L; Bigini P; De Cola L
    ACS Nano; 2021 Jun; 15(6):9701-9716. PubMed ID: 34009950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of zinc oxide nanoparticles on Kupffer cell phagosomal motility, bacterial clearance, and liver function.
    Watson CY; Molina RM; Louzada A; Murdaugh KM; Donaghey TC; Brain JD
    Int J Nanomedicine; 2015; 10():4173-84. PubMed ID: 26170657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why nanoparticles prefer liver macrophage cell uptake in vivo.
    Ngo W; Ahmed S; Blackadar C; Bussin B; Ji Q; Mladjenovic SM; Sepahi Z; Chan WCW
    Adv Drug Deliv Rev; 2022 Jun; 185():114238. PubMed ID: 35367524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation.
    Luan X; Yuan H; Song Y; Hu H; Wen B; He M; Zhang H; Li Y; Li F; Shu P; Burnett JP; Truchan N; Palmisano M; Pai MP; Zhou S; Gao W; Sun D
    Biomaterials; 2021 Aug; 275():120910. PubMed ID: 34144373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats.
    Moghimi SM; Gray T
    Clin Sci (Lond); 1997 Oct; 93(4):371-9. PubMed ID: 9404230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo.
    Ergen C; Niemietz PM; Heymann F; Baues M; Gremse F; Pola R; van Bloois L; Storm G; Kiessling F; Trautwein C; Luedde T; Lammers T; Tacke F
    Biomaterials; 2019 Jun; 206():49-60. PubMed ID: 30925288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Kupffer cells to liposome accumulation in the liver.
    Samuelsson E; Shen H; Blanco E; Ferrari M; Wolfram J
    Colloids Surf B Biointerfaces; 2017 Oct; 158():356-362. PubMed ID: 28719856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress of macrophage vesicle-based drug delivery systems.
    Xu WJ; Cai JX; Li YJ; Wu JY; Xiang D
    Drug Deliv Transl Res; 2022 Oct; 12(10):2287-2302. PubMed ID: 34984664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.
    Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ
    Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.